X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-09-18 | BBD | Bank Bradesco | De Oliveira Andre Luis Duarte | Exec Officer | P - Purchase | $17.98 | +63,861 | 307,923 | +26% | +$1,148,221 | |||||
| M | 2026-10-12 | BZUN | Baozun Inc. | Qiu Wenbin | CEO | P - Purchase | $3.40 | +11,800 | 1,678,572 | +1% | +$40,166 | |||||
| AM | 2026-09-25 | CINT | Ci&T Inc | Gon Cesar Nivaldo | CEO, 10% | P - Purchase | $2.90 | +8,816 | 75,208 | +13% | +$25,531 | |||||
2026-10-09 | CTNT | Cheetah Net Supply Chain Service Inc. | Liu Huan | See Remarks | P - Purchase | $3.30 | +100,000 | 101,358 | >999% | +$330,000 | ||||||
2026-10-13 | GME | Gamestop Corp. | Cohen Ryan | Pres, CEO, COB | P - Purchase | $26.98 | +844,130 | 42,492,652 | +2% | +$22,774,728 | ||||||
2026-10-08 | IIPR | Innovative Industrial Properties Inc | Gold Alan D | Exec COB | P - Purchase | $25.00 | +40,000 | 40,000 | New | +$1,000,000 | ||||||
2026-10-14 | INBX | Inhibrx Biosciences, Inc. | Lappe Mark | CEO | P - Purchase | $84.56 | +10,040 | 970,453 | +1% | +$848,977 | ||||||
| M | 2026-10-01 | KIO | Kkr Income Opportunities Fund | Pimentel Rudy | Pres | P - Purchase | $10.22 | +4,000 | 15,154 | +36% | +$40,890 | |||||
2026-10-09 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer, 10% | P - Purchase | $5.54 | +45,126 | 1,028,037 | +5% | +$249,998 | ||||||
| D | 2026-10-13 | RTSN | Retension Pharmaceuticals, Inc. | Keller Eric L. | CEO | P - Purchase | $12.00 | +20,800 | 464,407 | +5% | +$249,600 | |||||
| M | 2026-10-08 | SAR | Saratoga Investment Corp. | Oberbeck Christian L | CEO, Dir | P - Purchase | $14.86 | +30,000 | 973,996 | +3% | +$445,800 | |||||
2026-10-08 | SWZ | Total Return Securities Fund | Goldstein Phillip | Secretary | P - Purchase | $5.73 | +5,000 | 124,229 | +4% | +$28,637 | ||||||
2026-10-09 | TDIC | Dreamland Ltd | Seto Wai Yue | CEO, 10% | P - Purchase | $2.00 | +300,000 | 2,569,890 | +13% | +$600,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |